main content start
Invokamet and Invokamet XR are a combination oral medication of canagliflozin and metformin. Canagliflozin is in the SGLT-2 inhibitor class of drugs. It blocks glucose from being reabsorbed by the kidneys, and excess glucose is released in the urine. Metformin decreases the glucose released from the liver.
Medications in the SGLT-2 inhibitor class may offer heart and kidney benefits for people with cardiovascular disease.
This medication should be taken in the morning, and increased water intake throughout the day is recommended. It is approved for adults and children 10 years and over with type 2 diabetes.
- Along with diet and exercise, Invokamet (a combination of canagliflozin and metformin) and Invokamet XR are oral diabetes medicines that help manage blood glucose levels in adults and children age 10 years and over with type 2 diabetes. It is not for treating type 1 diabetes.
- This medication should be taken in the morning, and increased water intake throughout the day is recommended. Invokamet and Invokamet XR are usually taken with food.
- Invokamet XR is the extended-release form of the medication.
- Medications like Invokamet and Invokamet XR may offer heart benefits for people with type 2 diabetes and cardiovascular disease. It may also offer kidney benefits for people with kidney problems caused by type 2 diabetes.
- Common side effects may include urinating more than usual, headache, weakness, gas, stomach pain, indigestion, nausea, vomiting, or diarrhea.
Invokamet and Invokamet XR Specs
Key specification
Generic Name
Canagliflozin and Metformin
Approved for Kids
10+ with type 2 diabetes
Drug Class
SGLT-2 inhibitors
General Information
Product Name
Invokamet and Invokamet XR
Product Type
Oral Medications
Brand
Janssen Pharmaceuticals
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
